Report on the first PVL-positive community acquired MRSA strain in Latvia

E Miklasevics; S Haeggman; A Balode; B Sanchez; A Martinsons; B Olsson-Liljequist; U Dumpis

Report on the first PVL-positive community acquired MRSA strain in Latvia

Euro Surveill. 2004 Nov;9(11):29-30.

Authors

E Miklasevics¹, S Haeggman, A Balode, B Sanchez, A Martinsons, B Olsson-Liljequist, U Dumpis

Affiliation

¹ P. Stradins Clinical University Hospital, Riga, Latvia.

PMID: 15591692

Abstract

Infections by community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) have been reported worldwide. Here we present characterisation of the first CA-MRSA isolated in Latvia. A PVL-positive ST30-MRSA-IV strain was isolated from a nasal swab and the central venous catheter of a patient with fever and multiple organ failure. The PFGE pattern of this strain was identical to pattern SE00-3 of MRSA isolated in Sweden from 29 patients during 2000-2003. This strain is related to the South Pacific area, and its appearance in Sweden and Latvia demonstrates its global spread.

Publication types

Case Reports

MeSH terms

Bacterial Toxins
Catheterization, Central Venous
Community-Acquired Infections / drug therapy
Community-Acquired Infections / epidemiology
Community-Acquired Infections / microbiology
Exotoxins
Humans
Latvia / epidemiology
Leukocidins
Male
Methicillin Resistance*
Middle Aged
Staphylococcal Infections / drug therapy*
Staphylococcal Infections / epidemiology
Staphylococcal Infections / microbiology
Staphylococcus aureus / chemistry*
Staphylococcus aureus / drug effects
Staphylococcus aureus / isolation & purification

Substances

Bacterial Toxins
Exotoxins
Leukocidins
Panton-Valentine leukocidin